UWELL Biopharma
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma (NCT04717999) | UWELL Biopharma | 2021-09-01 |
| Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma (NCT04296461) | UWELL Biopharma | 2020-07-27 |
| Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma (NCT03811457) | UWELL Biopharma | 2017-06-01 |
Track UWELL Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.